Skip to main content

Table 4 Genotype frequencies of the SNPs and their associations with risk of endometrial cancer

From: Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk

SNP Model Genotype Case Control Without adjustment With adjustment of age
OR (95% CI) p OR (95% CI) p
rs118050317 Co-dominant GG 268 282 1   1  
   CG 74 61 1.28 (0.87–1.86) 0.206 1.28 (0.88–1.87) 0.202
   CC 8 1 8.42 (1.05–67.76) 0.045* 8.43 (1.05–67.89) 0.045*
  Dominant GG 268 282 1   1  
   CG + CC 82 62 1.39 (0.96–2.01) 0.080 1.40 (0.96–2.02) 0.078
  Recessive GG + CG 342 343 1   1  
   CC 8 1 8.02 (1.00–64.50) 0.050 8.03 (1.00–64.52) 0.050
  Log-additive 1.46 (1.04–2.06) 0.029* 1.47 (1.04–2.07) 0.029*
  1. OR odds ratio, 95% CI 95% confidential interval
  2. *p < 0.05 indicates statistical significance